Korean J Gastroenterol.  2017 May;69(5):267-269. 10.4166/kjg.2017.69.5.267.

The Clinical Impact of AST-Platelet Ratio Index for Non-invasive Hepatic Fibrosis in the Patients with Chronic Hepatitis B

• Heo NY

• KMID: 2383383
• DOI: http://doi.org/10.4166/kjg.2017.69.5.267

Abstract

No abstract available.

MeSH Terms

Fibrosis*
Hepatitis B, Chronic*
Hepatitis, Chronic*
Humans

Reference

1. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001; 344:495–500.

2. Chen YP, Peng J, Hou JL. Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Hepatol Int. 2013; 7:356–368.

3. Shin JW, Park NH. Clinical application of non-invasive diagnostic tests for liver fibrosis. Korean J Gastroenterol. 2016; 68:4–9.

4. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38:518–526.

5. Lin ZH, Xin YN, Dong QJ, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011; 53:726–736.

6. Sim SJ, Cheong JY, Cho SW, et al. Efficacy of AST to platelet ratio index in predicting severe hepatic fibrosis and cirrhosis in chronic hepatitis B virus infection. Korean J Gastroenterol. 2005; 45:340–347.

7. Shin WG, Park SH, Jang MK, et al. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis. 2008; 40:267–274.

8. Ucar F, Sezer S, Ginis Z, et al. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B. Eur J Gastroenterol Hepatol. 2013; 25:1076–1081.

9. Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology. 2015; 61:292–302.

10. Guidelines for the prevention, care and treatment of persons with chronic hepatiti B infection. [Internet]. Geneva: World Health Organization (WHO);2015. 03. cited 2017 May 8. Available from: http://www.who.int/hepatitis/publications/hepatitis-b-guidelines/en/.

11. Kim WR, Berg T, Asselah T, et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol. 2016; 64:773–780.

12. Bang CS, Kang HY, Choi GH, Kim SB, Lee W, Song IH. The Performance of Serum Biomarkers for Predicting Fibrosis in Patients with Chronic Viral Hepatitis. Korean J Gastroenterol. 2017; 69:298–307.